Decades of substantial U.S. Government investment in mRNA technology paved way for COVID-19 vaccines Coronavirus Disease COVID mRNA Vaccines BrighamWomens harvardmed Harvard uthsc
By Bhavana KunkalikarMar 6 2023Reviewed by Benedette Cuffari, M.Sc. In a recent study published in The BMJ, researchers explore the United States public funding for the development of coronavirus disease 2019 messenger ribonucleic acid vaccines.
Once the pandemic started in 2020, the United States made enormous financial investments in completing clinical trials and issued advance purchases ensuring millions of vaccine doses before their safety and effectiveness had been wholly proven. The team reviewed scientific data describing the history of SARS-CoV-2 mRNA vaccine development and considered four essential inventions. These inventions included lipid nanoparticle development as a drug delivery system, production, and alteration of mRNA, along with small interfering RNA , the definition of the prefusion SARS-CoV-2 "spike" protein structure, and RNA vaccine biotechnology development for human use.
The researchers created search terms by associating each scientist's name with a standard term characterizing the researcher's invention. For example, the search terms included the scientist name and nanoparticle or lipid or lipid nanoparticle; scientist name and siRNA or mRNA; scientist name and spike or perfusion; scientist name and immune* or vaccin*; and scientist name and SARS-CoV-2 or COVID-19 or coronavirus.
Further funding by the BARDA and Department of Defense raised the total U.S. public investment for pre-pandemic research and development to almost $337 million. This included a total of USD 31.9 billion from 1985 to March 2022, including spending on research, development, and vaccine supply. From the pandemic's beginning in 2020 to March 2022, the U.S. government expended at least $2.3 billion in the research and development of COVID-19 mRNA vaccines. In addition, BARDA funded Moderna's clinical trials, whereas the NIH funded other clinical trials, all the while investments were also made in manufacturing and fundamental or translational science.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning - Molecular MedicineBackground Survivors of acute COVID-19 often suffer prolonged, diffuse symptoms post-infection, referred to as “Long-COVID”. A lack of Long-COVID biomarkers and pathophysiological mechanisms limits effective diagnosis, treatment and disease surveillance. We performed targeted proteomics and machine learning analyses to identify novel blood biomarkers of Long-COVID. Methods A case–control study comparing the expression of 2925 unique blood proteins in Long-COVID outpatients versus COVID-19 inpatients and healthy control subjects. Targeted proteomics was accomplished with proximity extension assays, and machine learning was used to identify the most important proteins for identifying Long-COVID patients. Organ system and cell type expression patterns were identified with Natural Language Processing (NLP) of the UniProt Knowledgebase. Results Machine learning analysis identified 119 relevant proteins for differentiating Long-COVID outpatients (Bonferonni corrected P | 0.01). Protein combinations were narrowed down to two optimal models, with nine and five proteins each, and with both having excellent sensitivity and specificity for Long-COVID status (AUC = 1.00, F1 = 1.00). NLP expression analysis highlighted the diffuse organ system involvement in Long-COVID, as well as the involved cell types, including leukocytes and platelets, as key components associated with Long-COVID. Conclusions Proteomic analysis of plasma from Long-COVID patients identified 119 highly relevant proteins and two optimal models with nine and five proteins, respectively. The identified proteins reflected widespread organ and cell type expression. Optimal protein models, as well as individual proteins, hold the potential for accurate diagnosis of Long-COVID and targeted therapeutics.
続きを読む »
Researchers optically evoke tachycardia enhanced anxiety-like behaviourIn a recent study published in the journal Nature, researchers devised a non-invasive optogenetic and wearable cardiac pacemaker for accurate and specific control of cardiac rhythm for ≤900 beats per minute (bpm), enabled by micro-light-emitting display (LED) harness and systemic channelrhodopsin delivery.
続きを読む »
The next pandemic: Researchers develop tool to identify existing drugs to use in a future outbreakA global team of researchers has created an algorithmic tool that can identify existing drugs in order to combat future pandemics. The work, reported in the Cell Press journal Heliyon, offers the possibility of responding more quickly to public-health crises.
続きを読む »
Unnamed Murder Victim, Known for Decades as ‘Granby Girl,' Identified by AuthoritiesDecades after the body of a young woman was found in western Massachusetts, who has only been known as ‘Granby Girl’, authorities been able to identify the woman by using a combination of advances in DNA technology and “old-fashioned police work,” law enforcement announced during a news conference Monday morning. The woman, whose body was found on Nov. 15, 1978,…
続きを読む »
China’s lowest growth target in decades signals new era of caution\n\t\t\tKeep abreast of significant corporate, financial and political developments around the world.\n\t\t\tStay informed and spot emerging risks and opportunities with independent global reporting, expert\n\t\t\tcommentary and analysis you can trust.\n\t\t
続きを読む »
Trial emulation shows the effectiveness of the COVID-19 vaccine in improving long COVID symptomsTrial emulation shows the effectiveness of the COVID-19 vaccine in improving long COVID symptoms univ_spn COVID19 SARSCoV2 LongCOVID Vaccine Effectiveness
続きを読む »